# High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers

> **NCT05227755** · NA · COMPLETED · sponsor: **University of Florida** · enrollment: 15 (actual)

## Conditions studied

- Renal Failure
- Chronic Kidney Disease Requiring Chronic Dialysis

## Interventions

- **DIETARY_SUPPLEMENT:** Soy protein isolate
- **DIETARY_SUPPLEMENT:** Whey protein isolate

## Key facts

- **NCT ID:** NCT05227755
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-05
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-11-21
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227755, "High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05227755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*